Cite
HARVARD Citation
Swain, S. et al. (2022). Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management. Cancer treatment reviews. p. . [Online].